A study of the effect of gender on interferon beta-1a (Avonex® 30 mcg) treatment in patients with multiple sclerosis

被引：0
作者：
Munschauer, FE
Herndon, R
Sandrock, AW
Tsao, E
Berkhoff, JE
Stubbendick, A
机构：
[1] Jacobs Neurol Inst, Buffalo, NY USA
[2] Univ Mississippi, Jackson, MS 39216 USA
[3] Biogen Idec, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS | 2005年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S78 / S78
页数：1
相关论文
共 50 条
[21]   Meningioma growth during interferon beta-1a treatment for multiple sclerosis [J].
Pinto Gama, Hugo Pereira ;
da Rocha, Antonio Jose ;
da Silva, Carlos Jorge ;
Mendes, Maria Fernanda ;
Veiga, Jose Carlos Esteves ;
Lancellotti, Carmen Lucia Penteado ;
Andrade, Victor Piana ;
Tilbery, Charles Peter .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2008, 66 (2B) :402-404
[22]   Interferon beta-1a and intravenous immunoglobulin treatment for multiple sclerosis in Iran [J].
Kalanie, H ;
Gharagozli, K ;
Hemmatie, A ;
Ghorbanie, M ;
Kalanie, AR .
EUROPEAN NEUROLOGY, 2004, 52 (04) :202-206
[23]   Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a [J].
Pohl, D ;
Rostasy, K ;
Gärtner, J ;
Hanefeld, F .
NEUROLOGY, 2005, 64 (05) :888-890
[24]   Cost effectiveness analysis of interferon beta-1a (Avonex®) in pre-clinically definite multiple sclerosis (CDMS) [J].
Iskedjian, M ;
Walker, J ;
Gray, T ;
Vicente, C ;
Einarson, T ;
Gehshan, A .
VALUE IN HEALTH, 2004, 7 (03) :290-290
[25]   Retinopathy secondary to treatment with interferon beta-1a in a patient with multiple sclerosis [J].
Mallada-Frechín, J ;
Abellin-Miralles, I ;
Alfaro-Beltra, ML ;
Medrano, V ;
Muñoz-Gil, MB ;
Fernández-Izquierdo, S ;
Piqueras-Rodríguez, L .
REVISTA DE NEUROLOGIA, 2005, 40 (08) :482-484
[26]   Significance of serum neutralising antibodies to Avonex' (IFN beta-1a) in multiple sclerosis [J].
Rudick, RA ;
Jones, W ;
Alam, J ;
Simonian, N ;
Campion, M ;
Jacobs, L ;
Herndon, R ;
Richert, J ;
Salazar, A ;
Cookfair, D ;
Simon, J ;
Coats, M ;
Goodkin, D ;
Mass, M .
NEUROLOGY, 1997, 48 (03) :5003-5003
[27]   The effect of interferon beta-1a on spasticity in primary progressive multiple sclerosis [J].
Leary, SM ;
Thompson, AJ .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2004, 75 (03) :508-509
[28]   Rebif - Interferon beta-1a - SERONO - Second interferon beta-1a product for relapsing multiple sclerosis [J].
不详 .
FORMULARY, 2002, 37 (04) :169-169
[29]   Subcutaneous Interferon Beta-1a in Pediatric Multiple Sclerosis: A Retrospective Study [J].
Tenembaum, Silvia N. ;
Banwell, Brenda ;
Pohl, Daniela ;
Krupp, Lauren B. ;
Boyko, Alexey ;
Meinel, Michael ;
Lehr, Lorenz ;
Rocak, Sanda ;
di Cantogno, Elisabetta Verdun ;
Moraga, Margaretha Stam ;
Ghezzi, Angelo .
JOURNAL OF CHILD NEUROLOGY, 2013, 28 (07) :849-856
[30]   Appropriate use of interferon beta-1a in multiple sclerosis [J].
Jacobs, L ;
Brownscheidle, CM .
BIODRUGS, 1999, 11 (03) :155-163
12345